Verrica Pharmaceuticals Inc. (VRCA) › Capital ExpendituresVerrica Pharmaceuticals Inc. (VRCA) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2018: $774.0K2019: $682.0K2020: $1.47M2021: $883.0K2022: $302.0K2023: $362.0K2024: $27.0K2025: $0$02018Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$0-100.0%2024$27.0K-92.5%2023$362.0K+19.9%2022$302.0K-65.8%2021$883.0K-39.9%2020$1.47M+115.5%2019$682.0K-11.9%2018$774.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share